-
Compounds that block the production of damaging molecules might shed light on their role in disease—and lead to new therapies.
Biomedical ResearchNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesScientific ResearchBiomedical Science -
Biomedical ResearchDrug DiscoveryNovartis Institutes for BioMedical ResearchScientific ResearchBiomedical Science
-
Biomedical ResearchNovartis Institutes for BioMedical ResearchScientific ResearchBiomedical Science
-
Experts call for significant changes to facilitate the discovery of new treatments.
Drug DiscoveryNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesClinical ResearchBiomedical Science -
Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.
Novartis Institutes for BioMedical ResearchReimagine MedicineNew Scientific DiscoveriesScientific ResearchBiomedical Science -
Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
Novartis Institutes for BioMedical ResearchPostdoc ProgramNew Scientific DiscoveriesBiomedical ScienceGenetic Disease -
Inspired by her mother, Vicky Qi leads drug discovery teams.
Novartis Institutes for BioMedical ResearchResearch JobsCancer Research InstituteBiomedical Science -
Novartis CEO Vas Narasimhan answers questions about COVID-19.
Biomedical ResearchCOVID-19Data ScienceDiseasesInfectious DiseasesClinical TrialsBiomedical Science -
Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub
Drug DiscoveryNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesBiomedical Science -
Novartis researcher Joana Silva had a life-changing experience with a mentor.
Biomedical ResearchCancerWomen in ScienceBiomedical Science